CRC Macrodissect AI

CRC Macrodissect AI is seamlessly integrated into the HALO AP® platform, which is an AI-driven, pathologist-focused system designed to enhance anatomic pathology workflows. This integration facilitates the use of advanced image analysis techniques within the platform.

While CRC Macrodissect AI is accessible through the HALO AP® enterprise digital pathology platform, it is important to note that it is not classified as a medical device in the EU/UK and is not intended for diagnostic purposes. In the USA, it is designated for research use only and lacks FDA clearance for clinical diagnostic applications.

HALO AP® itself is CE-IVDR marked for in-vitro diagnostic use in Europe, the UK, and Switzerland, and is also for research use only in the USA. The platform ensures compliance with several regulatory standards, including FDA 21 CFR Part 11, HIPAA, and GDPR.

Key Features and Benefits:

• Fully integrated into the HALO AP® platform for streamlined pathology workflows.
• Designed for research use, providing advanced image analysis capabilities.
• Compliance with major regulatory standards, ensuring data protection and integrity.

For those interested in exploring CRC Macrodissect AI further, Indica Labs offers live demos and additional information upon request. Technical support and software maintenance services are also available to assist users in maximizing the platform's capabilities.